Head-to-head · WeighScore
eMI Aesthetics vs FuturHealth
By GLP-1 ScorecardUpdated
Score comparison
eMI Aesthetics has the higher recorded score — 70.3/100 to 65.6/100.
eMI Aesthetics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMI Aesthetics is a US direct-to-consumer telehealth brand offering doctor-guided GLP-1 weight loss programs to eligible patients in all 50 states.
Before you choose
Before comparing the headline prices, the eMI Aesthetics review and the FuturHealth review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, eMI Aesthetics vs Genesis Health and FormidableMD vs FuturHealth compare each of them with another graded program, and the list of alternatives to eMI Aesthetics ranks the programs closest to eMI Aesthetics on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | eMI Aesthetics | FuturHealth |
|---|---|---|
| WeighScore | 70.3/100 | 65.6/100 |
| Grade | C | C |
| Site position | #118 | #235 |
| Semaglutide | $179/mo (all doses, compounded) | $198/mo (Wegovy pill intro dose) |
| Tirzepatide | Not disclosed | $395/mo (Zepbound KwikPen intro dose) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Available to eligible patients in all 50 states
- Offers both semaglutide and tirzepatide, plus an oral semaglutide option
- Intake and provider visits run through OpenLoop Health, an established telehealth network
What to consider
- Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
- No fill pharmacy or named medical director is publicly listed
- Support appears limited to email, with no phone number or hours published
Strengths
- Names the brand and format on its introductory price cards.
- Publishes its subscription cancellation and refund terms.
What to consider
- Introductory figures leave continuing and all-in charges open.
- The membership guarantee excludes medication and most third-party charges.
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.